Author name: Yali Friedman

Send in the Clones Will a relaxed attitude to regulation make Singapore the stem-cell-research capital of the world?

New breed of VCs banking on biotech As the era of rock-star venture capitalists investing in Internet start-ups appears to

Biology Seeks a Few Good Geeks The declaration is perhaps not as stirring as Uncle Sam calling patriotic men into

Biotechs on edge as money evaporates Seattle’s biotech industry is working on some of the most complicated medical science in

Making a Run for the Border-For Canadian Prescription Drugs Picture a tour bus filled with American seniors heading for a

Biotech industry seeks control of its destiny Human Genome Sciences and a small but determined group of its peers are

Singapore’s biotech bid Singapore is rolling out the red carpet to foreign scientists and entrepreneurs in an ambitious bid to

Singapore’s biotech bid Singapore is rolling out the red carpet to foreign scientists and entrepreneurs in an ambitious bid to

Big Pharma: Getting Too Big for Its Own Good? A study by McKinsey & Co. earlier this year looked at

European Patent Office bars human cloning in patent The European Patent Office added restrictions on Wednesday to a controversial patent